Home
Conditions
Scleroderma, Systemic

Clinical trial condition

Scleroderma, Systemic

Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.

433 public trials 124 recruiting studies

Refine in advanced search Browse all conditions

Scleroderma, Systemic trial results

Recruiting

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Antiphospholipid Syndrome, +29 more
Locations: The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

CAR-T Cells Therapy for Patients With Autoimmune Diseases

NCT07052565

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations: Anhui Provincial Hospital Hefei, China

View Trial Details

Recruiting

TENS in Scleroderma

NCT06646913

Conditions: Connective Tissue Diseases, Digestive System Diseases, Gastrointestinal Diseases, +12 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Recruiting

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

NCT05989763

Conditions: Autonomic Dysfunction, Autonomic Nervous System Diseases, Connective Tissue Diseases, +11 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Recruiting

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

NCT06980597

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: Beijing Boren Hospital Beijing, China

Beijing GoBroad Hospital Beijing, China

View Trial Details

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

NCT05892614

Conditions: Connective Tissue Diseases, Fibrosis, Infections, +11 more
Locations: aTyr Investigative Site Los Angeles, California, United States

aTyr Investigative Site San Diego, California, United States

aTyr Investigative Site Miami, Florida, United States

aTyr Investigative Site Chicago, Illinois, United States

View all 15 locations

View Trial Details

Recruiting

An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases

NCT06503224

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations: Hunan Siweikang Therapeutic Co.Ltd Changsha, Hunan, China

View Trial Details

Recruiting

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

NCT05785065

Conditions: Connective Tissue Diseases, Interstitial Lung Disease, Lung Diseases, +7 more
Locations: Centre hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada

Jewish General Hospital - CIUSSS-COMTL Montreal, Quebec, Canada

Institut Universitaire de Cardiologie et Pneumologie de Québec Québec, Quebec, Canada

View Trial Details

Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

NCT05016804

Conditions: Connective Tissue Diseases, Scleroderma, Diffuse, Scleroderma, Systemic, +3 more
Locations: Medical Surgical Associates Center St John's, Antigua and Barbuda

Center for Investigation in Tissue Engineering and Cellular Therapy Buenos Aires, Argentina

View Trial Details

Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

NCT06794008

Conditions: ANCA-associated Vasculitis, Acquired Thrombotic Thrombocytopenic Purpura, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +62 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Scleroderma, Systemic

Scleroderma, Systemic trial results

Related conditions